Ursolic acid increases energy expenditure through enhancing free fatty acid uptake and β-oxidation via an UCP3/AMPK-dependent pathway in skeletal muscle

Molecular Nutrition and Food Research

Volumn 59, Issue 8, 2015, Pages 1491-1503

  Chu, Xia ^a   He, Xuan ^a   Shi, Zhiping ^a   Li, Chunjuan ^a   Guo, Fuchuan ^a   Li, Songtao ^a   Li, Ying ^a   Na, Lixin ^a   Sun, Changhao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

AMP activated protein kinase; Fatty acid oxidation; Free fatty acid uptake; Uncoupling protein 3; Ursolic acid

Indexed keywords

RATTUS;

AMP-ACTIVATED PROTEIN KINASE ALPHA1 PROTEIN, RAT; ANTIOBESITY AGENT; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 3; TRITERPENE; URSOLIC ACID;

ABSORPTION; ADVERSE EFFECTS; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CELL LINE; DIET THERAPY; DIETARY SUPPLEMENT; ENERGY METABOLISM; ENZYMOLOGY; GENETICS; GERMFREE ANIMAL; LIPID DIET; MALE; METABOLISM; MOUSE; OBESITY; RANDOMIZATION; RNA INTERFERENCE; SECOND MESSENGER; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT;

ABSORPTION, PHYSIOLOGICAL; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTI-OBESITY AGENTS; CELL LINE; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; ION CHANNELS; MALE; MICE; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; OBESITY; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; SECOND MESSENGER SYSTEMS; SPECIFIC PATHOGEN-FREE ORGANISMS; TRITERPENES;

EID: 84938547388     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400670     Document Type: Article

References (55)

1. Saltiel, A. R., Kahn, C. R., Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414, 799-806.
2. Resnick, H. E., Valsania, P., Halter, J. B., Lin, X., Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J. Epidemiol. Community Health 2000, 54, 596-602.
3. Kim, S. K., Kim, H. J., Hur, K. Y., Choi, S. H. et al., Visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseases. Am. J. Clin. Nutr. 2004, 79, 593-599.
4. de Jongh, R. T., Serne, E. H., Ijzerman, R. G., de Vries, G. et al., Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy. Diabetes 2004, 53, 2873-2882.
5. Wakil, S. J., Abu-Elheiga, L. A., Fatty acid metabolism: target for metabolic syndrome. J. Lipid Res. 2009, 50 (Suppl), S138-S143.
6. Shishodia, S., Majumdar, S., Banerjee, S., Aggarwal, B. B., Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res. 2003, 63, 4375-4383.
7. Tsai, S. J., Yin, M. C., Antioxidative and anti-inflammatory protection of oleanolic acid and ursolic acid in PC12 cells. J. Food Sci. 2008, 73, H174-H178.
8. Ullevig, S. L., Zhao, Q., Zamora, D., Asmis, R., Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis. Atherosclerosis 2011, 219, 409-416.
9. Baglin, I., Mitaine-Offer, A. C., Nour, M., Tan, K. et al, A review of natural and modified betulinic, ursolic and echinocystic acid derivatives as potential antitumor and anti-HIV agents. Mini Rev. Med. Chem. 2003, 3, 525-539.
10. Li, S., Liao, X., Meng, F., Wang, Y. et al., Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats. PLoS One 2014, 9, e86724.
11. Rao, V. S., de Melo, C. L., Queiroz, M. G., Lemos, T. L. et al., Ursolic acid, a pentacyclic triterpene from Sambucus australis, prevents abdominal adiposity in mice fed a high-fat diet. J. Med. Food 2011, 14, 1375-1382.
12. Sundaresan, A., Harini, R., Pugalendi, K. V., Ursolic acid and rosiglitazone combination alleviates metabolic syndrome in high fat diet fed C57BL/6J mice. Gen. Physiol. Biophys. 2012, 31, 323-333.
13. Jayaprakasam, B., Olson, L. K., Schutzki, R. E., Tai, M. H. et al., Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas). J. Agric. Food Chem. 2006, 54, 243-248.
14. Li, Y., Kang, Z., Li, S., Kong, T. et al., Ursolic acid stimulates lipolysis in primary-cultured rat adipocytes. Mol. Nutr. Food Res. 2010, 54, 1609-1617.
15. He, Y., Li, Y., Zhao, T., Wang, Y. et al., Ursolic acid inhibits adipogenesis in 3T3-L1 adipocytes through LKB1/AMPK pathway. PLoS One 2013, 8, e70135.
16. Hardie, D. G., The AMP-activated protein kinase pathway-new players upstream and downstream. J. Cell. Sci. 2004, 117, 5479-5487.
17. Dzamko, N., Schertzer, J. D., Ryall, J. G., Steel, R. et al., AMPK-independent pathways regulate skeletal muscle fatty acid oxidation. J. Physiol. 2008, 586, 5819-5831.
18. Luiken, J. J., Coort, S. L., Willems, J., Coumans, W. A. et al., Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 2003, 52, 1627-1634.
19. Samovski, D., Su, X., Xu, Y., Abumrad, N. A. et al., Insulin and AMPK regulate FA translocase/CD36 plasma membrane recruitment in cardiomyocytes via Rab GAP AS160 and Rab8a Rab GTPase. J. Lipid Res. 2012, 53, 709-717.
20. Corton, J. M., Gillespie, J. G., Hardie, D. G., Role of the AMP-activated protein kinase in the cellular stress response. Curr. Biol. 1994, 4, 315-324.
21. Luo, Z., Zang, M., Guo, W., AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol. 2010, 6, 457-470.
22. Costford, S. R., Seifert, E. L., Bezaire, V. M F. G., Bevilacqua, L. et al., The energetic implications of uncoupling protein-3 in skeletal muscle. Appl. Physiol. Nutr. Metab. 2007, 32, 884-894.
23. Gong, D. W., He, Y., Karas, M., Reitman, M., Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin. J. Biol. Chem. 1997, 272, 24129-24132.
24. Clapham, J. C., Arch, J. R., Chapman, H., Haynes, A. et al., Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 2000, 406, 415-418.
25. Tiraby, C., Tavernier, G., Capel, F., Mairal, A. et al., Resistance to high-fat-diet-induced obesity and sexual dimorphism in the metabolic responses of transgenic mice with moderate uncoupling protein 3 overexpression in glycolytic skeletal muscles. Diabetologia 2007, 50, 2190-2199.
26. Choi, C. S., Fillmore, J. J., Kim, J. K., Liu, Z. X. et al., Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance. J. Clin. Invest. 2007, 117, 1995-2003.
27. Schrauwen, P., Xia, J., Bogardus, C., Pratley, R. E. et al., Skeletal muscle uncoupling protein 3 expression is a determinant of energy expenditure in Pima Indians. Diabetes 1999, 48, 146-149.
28. Schrauwen, P., Hardie, D. G., Roorda, B., Clapham, J. C. et al., Improved glucose homeostasis in mice overexpressing human UCP3: a role for AMP-kinase? Int. J. Obes. Relat. Metab. Disord. 2004, 28, 824-828.
29. Stoppani, J., Hildebrandt, A. L., Sakamoto, K., Cameron-Smith, D. et al., AMP-activated protein kinase activates transcription of the UCP3 and HKII genes in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2002, 283, E1239-E1248.
30. Zhou, M., Lin, B. Z., Coughlin, S., Vallega, G. et al., UCP-3 expression in skeletal muscle: effects of exercise, hypoxia, and AMP-activated protein kinase. Am. J. Physiol. Endocrinol. Metab. 2000, 279, E622-E629.
31. Peronnet, F., Massicotte, D., Table of nonprotein respiratory quotient: an update. Can. J. Sport Sci. 1991, 16, 23-29.
32. Liu, L., Li, Y., Guan, C., Li, K. et al., Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010, 878, 2817-2825.
33. Guo, F., Huang, C., Liao, X., Wang, Y. et al., Beneficial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters. Mol. Nutr. Food Res. 2011, 55, 1809-1818
34. Folch, J., Lees, M., Sloane Stanley, G. H., A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497-509.
35. Park, K. S., Raspberry ketone increases both lipolysis and fatty acid oxidation in 3T3-L1 adipocytes. Planta Med. 2010, 76, 1654-1658.
36. Holla, V. R., Wu, H., Shi, Q., Menter, D. G. et al., Nuclear orphan receptor NR4A2 modulates fatty acid oxidation pathways in colorectal cancer. J. Biol. Chem. 2011, 286, 30003-30009.
37. Niu, Y., Li, S., Na, L., Feng, R. et al., Mangiferin decreases plasma free fatty acids through promoting its catabolism in liver by activation of AMPK. PLoS One 2012, 7, e30782.
38. Lu, N., Li, Y., Qin, H., Zhang, Y. L. et al., Gossypin up-regulates LDL receptor through activation of ERK pathway: a signaling mechanism for the hypocholesterolemic effect. J. Agric. Food Chem. 2008, 56, 11526-11532.
39. Kim, J., Jang, D. S., Kim, H., Kim, J. S., Anti-lipase and lipolytic activities of ursolic acid isolated from the roots of Actinidia arguta. Arch. Pharm. Res. 2009, 32, 983-987.
40. Liu, Y., Tian, W., Ma, X., Ding, W., Evaluation of inhibition of fatty acid synthase by ursolic acid: positive cooperation mechanism. Biochem. Biophys. Res. Commun. 2010, 392, 386-390.
41. Sundaresan, A., Radhiga, T., Pugalendi, K. V., Effect of ursolic acid and Rosiglitazone combination on hepatic lipid accumulation in high fat diet-fed C57BL/6J mice. Eur. J. Pharmacol. 2014, 741, 297-303.
42. Jang, S. M., Kim, M. J., Choi, M. S., Kwon, E. Y. et al., Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice. Metab. Clin. Exp. 2010, 59, 512-519.
43. Yang, Y., Zhao, Z., Liu, Y., Kang, X. et al., Suppression of oxidative stress and improvement of liver functions in mice by ursolic acid via LKB1-AMP-activated protein kinase signaling. J. Gastroenterol. Hepatol. 2015, 30, 609-618.
44. Son, H. S., Kwon, H. Y., Sohn, E. J., Lee, J. H. et al., Activation of AMP-activated protein kinase and phosphorylation of glycogen synthase kinase3 β mediate ursolic acid induced apoptosis in HepG2 liver cancer cells. Phytother. Res. 2013, 27, 1714-1722.
45. Zheng, Q. Y., Jin, F. S., Yao, C., Zhang, T. et al., Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells. Biochem. Biophys. Res. Commun. 2012, 419, 741-747.
46. Liu, Y., Wan, Q., Guan, Q., Gao, L. et al., High-fat diet feeding impairs both the expression and activity of AMPKa in rats' skeletal muscle. Biochem. Biophys. Res. Commun. 2006, 339, 701-707.
47. Erlanson-Albertsson, C., Uncoupling proteins-a new family of proteins with unknown function. Nutr. Neurosci. 2002, 5, 1-11.
48. Boss, O., Samec, S., Paoloni-Giacobino, A., Rossier, C. et al., Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett. 1997, 408, 39-42.
49. Garcia-Martinez, C., Sibille, B., Solanes, G., Darimont, C. et al., Overexpression of UCP3 in cultured human muscle lowers mitochondrial membrane potential, raises ATP/ADP ratio, and favors fatty acid vs. glucose oxidation. FASEB J. 2001, 15, 2033-2035.
50. Wang, S., Subramaniam, A., Cawthorne, M. A., Clapham, J. C., Increased fatty acid oxidation in transgenic mice overexpressing UCP3 in skeletal muscle. Diabetes Obes. Metab. 2003, 5, 295-301.
51. Bezaire, V., Spriet, L. L., Campbell, S., Sabet, N. et al., Constitutive UCP3 overexpression at physiological levels increases mouse skeletal muscle capacity for fatty acid transport and oxidation. FASEB J. 2005, 19, 977-979.
52. Gong, D. W., Monemdjou, S., Gavrilova, O., Leon, L. R. et al., Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J. Biol. Chem. 2000, 275, 16251-16257.
53. Vidal-Puig, A. J., Grujic, D., Zhang, C. Y., Hagen, T. et al., Energy metabolism in uncoupling protein 3 gene knockout mice. J. Biol. Chem. 2000, 275, 16258-16266.
54. Liobikas, J., Majiene, D., Trumbeckaite, S., Kursvietiene, L. et al., Uncoupling and antioxidant effects of ursolic acid in isolated rat heart mitochondria. J. Nat. Prod. 2011, 74, 1640-1644.
55. Viollet, B., Andreelli, F., Jørgensen, S. B., Perrin, C. et al., The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J. Clin. Invest. 2003, 111, 91-98.